Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Laura M. Chambers"'
Autor:
Quinn Kistenfeger, Ashley S. Felix, Caitlin E. Meade, Vincent Wagner, Kristin Bixel, Laura M. Chambers
Publikováno v:
Gynecologic Oncology Reports, Vol 54, Iss , Pp 101411- (2024)
Objectives: Due to low incidence of vulvar cancer (VC), incidence and predictors for development of venous thromboembolism (VTE) are poorly understood. We examined incidence and risk factors associated with VTE in patients undergoing surgery for VC.
Externí odkaz:
https://doaj.org/article/86ce4d41f9044a6798c765fd8027d8c1
Gastritis as an immunotherapy-related toxicity in the treatment of endometrial cancer: A case report
Publikováno v:
Gynecologic Oncology Reports, Vol 47, Iss , Pp 101174- (2023)
Gastritis related to immunotherapy use is a less commonly reported adverse effect. With increasing use of immunotherapy agents in the management of patients with endometrial cancer, even rare adverse effects are being seen more frequently in gynecolo
Externí odkaz:
https://doaj.org/article/93be8123b9524774bc184def30479cd8
Autor:
Laura M. Chambers, Meng Yao, Molly Morton, Morgan Gruner, Anna Chichura, Anthony B. Costales, Max Horowitz, Peter G. Rose, Chad M. Michener, Robert Debernardo
Publikováno v:
Gynecologic Oncology Reports, Vol 40, Iss , Pp 100951- (2022)
Objective (s): To evaluate travel distance in women with advanced or recurrent epithelial ovarian cancer (OC) undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) and the subsequent impact upon outcomes. Methods: An
Externí odkaz:
https://doaj.org/article/fee775c7d38845aca4c5ce4219ceedd8
Autor:
Laura M. Chambers, Danielle Chau, Meng Yao, Anthony B. Costales, Peter G. Rose, Chad M. Michener, Robert Debernardo, Roberto Vargas
Publikováno v:
Gynecologic Oncology Reports, Vol 38, Iss , Pp 100876- (2021)
Objective(s): To investigate the efficacy and safety of hyperthermic intraperitoneal chemotherapy (HIPEC) at the time of iterval debulking surgery (IDS) in women with advanced uterine serous carcinoma (USC) following neoadjuvant chemotherapy (NACT).
Externí odkaz:
https://doaj.org/article/7883a9329445405087a11cb5f46ae90d
Autor:
Jonathan T. Hunt, Laura M. Chambers, Meng Yao, Amy Joehlin-Price, Robert Debernardo, Peter G. Rose
Publikováno v:
Gynecologic Oncology Reports, Vol 37, Iss , Pp 100840- (2021)
Objective(s): To investigate the efficacy of pembrolizumab plus lenvatinib as a second-line or later-line therapy in women with advanced or recurrent uterine carcinosarcoma (UCS). Methods: A single-institution pharmacy database was queried for women
Externí odkaz:
https://doaj.org/article/c46ab3e278b6456fb18b9f4971ae7015
Autor:
Laura M. Chambers, Catherine H. Watson, Meng Yao, Kimberly Levinson, Ronald D. Alvarez, Ramez N. Eskander, Megan Buechel, Chad M. Michener, Amelia Jernigan
Publikováno v:
Gynecologic Oncology Reports, Vol 36, Iss , Pp 100755- (2021)
Authorship confers credit to those responsible for a publication. In 1985, the International Committee of Medical Journal Editors criteria were founded to standardize authorship assignment. We sought to investigate practices and values in authorship
Externí odkaz:
https://doaj.org/article/321e8d359cd64ef2b5504e647879949e
Publikováno v:
International Journal of Gynecologic Cancer. 33:465-472
ObjectiveTo determine whether frailty is associated with post-operative complications following surgery for vulvar cancer.MethodsThis retrospective study used a multi-institutional dataset from the National Surgical Quality Improvement Program (NSQIP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::29bfc3b8d6f002630191a8f7820566f8
https://doi.org/10.1136/ijgc-2022-004175
https://doi.org/10.1136/ijgc-2022-004175
Is there a 'low-risk' patient population in advanced epithelial ovarian cancer?: a critical analysis
Publikováno v:
American Journal of Obstetrics and Gynecology. 227:728-734
Ovarian cancer is the leading cause of gynecologic cancer-related death in the United States. Historically, studies have demonstrated that ovarian cancer is a heterogeneous disease with several patient and oncologic characteristics, including BRCA st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f09e984c28a2158ec512dbcd7d3491b0
https://doi.org/10.1016/j.ajog.2022.05.047
https://doi.org/10.1016/j.ajog.2022.05.047
Data from Disruption of the Gut Microbiota Confers Cisplatin Resistance in Epithelial Ovarian Cancer
Autor:
Ofer Reizes, Chad M. Michener, J. Mark Brown, Roberto Vargas, Peter Rose, Jan Claesen, Philip P. Ahern, Adeline Hajjar, Mohammed Dwidar, Sumita Dutta, Zeneng Wang, Amy S. Joehlin-Price, Peter Bazeley, Naseer Sangwan, Justin D. Lathia, Defne Bayik, Zahraa Alali, Lexie Trestan, Surabhi Tewari, Chad Braley, Rashmi Bharti, Emily L. Esakov Rhoades, Laura M. Chambers
Epithelial ovarian cancer (EOC) is the leading cause of gynecologic cancer death. Despite initial responses to intervention, up to 80% of patient tumors recur and require additional treatment. Retrospective clinical analysis of patients with ovarian
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::741c6440b86066bbf734f4577226911a
https://doi.org/10.1158/0008-5472.c.6514286.v1
https://doi.org/10.1158/0008-5472.c.6514286.v1
Autor:
Ofer Reizes, Chad M. Michener, J. Mark Brown, Roberto Vargas, Peter Rose, Jan Claesen, Philip P. Ahern, Adeline Hajjar, Mohammed Dwidar, Sumita Dutta, Zeneng Wang, Amy S. Joehlin-Price, Peter Bazeley, Naseer Sangwan, Justin D. Lathia, Defne Bayik, Zahraa Alali, Lexie Trestan, Surabhi Tewari, Chad Braley, Rashmi Bharti, Emily L. Esakov Rhoades, Laura M. Chambers
Supplemental Figures and Tables supporting manuscript.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23eb9039ed34bb43aaa0b1f6ae15d626
https://doi.org/10.1158/0008-5472.22432976
https://doi.org/10.1158/0008-5472.22432976